Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular

NCT07352007 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

HCC

Interventions

PROCEDURE: SBRT
DRUG: Sintilimab
PROCEDURE: Surgery

Sponsor

Lei ZHAO